title: Ivabradine and atrial fibrillation: what should we tell our patients?
authors.forename: Martin R
authors.initials: MR
authors.lastname: Cowie
mesh_terms: D000787:Angina Pectoris / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000139:chemically induced*; D001552:Benzazepines / Q000009:adverse effects / Q000494:pharmacology; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000494:pharmacology; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D000077550:Ivabradine; D054539:Medication Therapy Management; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment
chemical_list: D001552:Benzazepines; D002317:Cardiovascular Agents; D000077550:Ivabradine
keywords: Heart Failure; Pharmacology